Premium Monovision Versus Other Types of Monovision and Bilateral Trifocal Implantation.

NCT ID: NCT04618380

Last Updated: 2020-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2020-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary objective of this study was to compare the efficacy of premium monovision with Restor and Panoptix, against other prevalent monovision techniques and against bilateral Panoptix implantation in a sample of patients following lens-extraction surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Four study groups were formed according to the procedure and the intraocular lens technology that was used: a) Monovision Group (MoG), b) Multifocal Lens Group (MfG), c) Hybrid Monovision Group (HmG), and, d) Premium Monovision Group (PmG). Patients who have undergone one of the above categories of presbyopia correction surgery were selected to compare the effectiveness of these techniques by evaluating the uncorrected near, intermediate and distant visual acuity as well as the degree of subjective patient satisfaction, contrast sensitivity, dysphotopsia symptoms and spectacle independence .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Presbyopia Refractive Errors Cataract

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

pseudophakic presbyopic correction premium monovision myopic monovision multifocal intraocular lenses hybrid monovision

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bilateral trifocal implantation

Bilateral implantation of trifocal diffractive intraocular lenses (Panoptix, Alcon) targeting emmetropia

bUD-VA,bUN-RA, bUI-RA, bUI-CPS, bUN-CPS, contrast sensitivity

Intervention Type DIAGNOSTIC_TEST

The following clinical indexes are evaluated:

1. Binocular uncorrected distant visual acuity (bUD-VA) using the Greek version of the Early Treatment Diabetic Retinopathy Study Chart at four meters distance
2. Binocular uncorrected reading acuity at 60cm (bUI-RA) and at 40cm (bUN-RA), and
3. Binocular uncorrected critical print size at 60cm (bUI-CPS) and at 40cm (bUN-CPS).

All near and intermediate vision parameters are obtained using the Democritus Digital Acuity Reading Test (DDART), which is based on the Greek version of MNREAD.

Contrast sensitivity are evaluated with the Pelli-Robson test.

Myopic monovision

The dominant eye defocus is targeted to -0.50 diopters while the recessive one to -1.25 diopters with bilateral implantation of monofocal intraocular lenses (SN60WF, Alcon)

bUD-VA,bUN-RA, bUI-RA, bUI-CPS, bUN-CPS, contrast sensitivity

Intervention Type DIAGNOSTIC_TEST

The following clinical indexes are evaluated:

1. Binocular uncorrected distant visual acuity (bUD-VA) using the Greek version of the Early Treatment Diabetic Retinopathy Study Chart at four meters distance
2. Binocular uncorrected reading acuity at 60cm (bUI-RA) and at 40cm (bUN-RA), and
3. Binocular uncorrected critical print size at 60cm (bUI-CPS) and at 40cm (bUN-CPS).

All near and intermediate vision parameters are obtained using the Democritus Digital Acuity Reading Test (DDART), which is based on the Greek version of MNREAD.

Contrast sensitivity are evaluated with the Pelli-Robson test.

Hybrid monovision

Hybrid monovision combines a monofocal intraocular (SN60WF, Alcon) in the dominant eye and a trifocal diffractive intraocular lens (Panoptix, Alcon) in the recessive one

bUD-VA,bUN-RA, bUI-RA, bUI-CPS, bUN-CPS, contrast sensitivity

Intervention Type DIAGNOSTIC_TEST

The following clinical indexes are evaluated:

1. Binocular uncorrected distant visual acuity (bUD-VA) using the Greek version of the Early Treatment Diabetic Retinopathy Study Chart at four meters distance
2. Binocular uncorrected reading acuity at 60cm (bUI-RA) and at 40cm (bUN-RA), and
3. Binocular uncorrected critical print size at 60cm (bUI-CPS) and at 40cm (bUN-CPS).

All near and intermediate vision parameters are obtained using the Democritus Digital Acuity Reading Test (DDART), which is based on the Greek version of MNREAD.

Contrast sensitivity are evaluated with the Pelli-Robson test.

Premium monovision

Participants received a bifocal hybrid (refractive at the centre, diffractive at the periphery) intraocular lens (Restor +2.50 diopters, Alcon) in the dominant eye and a trifocal diffractive intraocular lens (Panoptix, Alcon) in the recessive one, targeting emmetropia in both eyes.

bUD-VA,bUN-RA, bUI-RA, bUI-CPS, bUN-CPS, contrast sensitivity

Intervention Type DIAGNOSTIC_TEST

The following clinical indexes are evaluated:

1. Binocular uncorrected distant visual acuity (bUD-VA) using the Greek version of the Early Treatment Diabetic Retinopathy Study Chart at four meters distance
2. Binocular uncorrected reading acuity at 60cm (bUI-RA) and at 40cm (bUN-RA), and
3. Binocular uncorrected critical print size at 60cm (bUI-CPS) and at 40cm (bUN-CPS).

All near and intermediate vision parameters are obtained using the Democritus Digital Acuity Reading Test (DDART), which is based on the Greek version of MNREAD.

Contrast sensitivity are evaluated with the Pelli-Robson test.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bUD-VA,bUN-RA, bUI-RA, bUI-CPS, bUN-CPS, contrast sensitivity

The following clinical indexes are evaluated:

1. Binocular uncorrected distant visual acuity (bUD-VA) using the Greek version of the Early Treatment Diabetic Retinopathy Study Chart at four meters distance
2. Binocular uncorrected reading acuity at 60cm (bUI-RA) and at 40cm (bUN-RA), and
3. Binocular uncorrected critical print size at 60cm (bUI-CPS) and at 40cm (bUN-CPS).

All near and intermediate vision parameters are obtained using the Democritus Digital Acuity Reading Test (DDART), which is based on the Greek version of MNREAD.

Contrast sensitivity are evaluated with the Pelli-Robson test.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of senile cataract with stage 2 nuclear opalescence according to the Lens Opacities Classification System III (LOCS-3) grading scale

Exclusion Criteria

* Manifest astigmatism \> 1.00 diopters
* Reports of headaches and/or eyestrain associated with visual activities
* Positive, pathologic ocular cover test (near \& distant) and / or the Mallett's disparity test (near \& distant) and the double Maddox rod test
* Endothelial cell count less than 1900/mm2
* Glaucoma
* intraocular pressure-lowering medications
* Former incisional surgery
* Former diagnosis of corneal disease
* Former diagnosis of fundus disease
* Diabetes
* Autoimmune diseases
* Mental diseases
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Democritus University of Thrace

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Georgios Labiris

Professor (Associate) of Democritus University of Thrace

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georgios Labiris, MD,PHD

Role: STUDY_CHAIR

Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Ophthalmology, University Hospital of Alexandroupolis

Alexandroupoli, Evros, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

References

Explore related publications, articles, or registry entries linked to this study.

Labiris G, Panagiotopoulou EK, Chatzimichael E, Tzinava M, Mataftsi A, Delibasis K. Introduction of a digital near-vision reading test for normal and low vision adults: development and validation. Eye Vis (Lond). 2020 Oct 22;7:51. doi: 10.1186/s40662-020-00216-0. eCollection 2020.

Reference Type RESULT
PMID: 33102611 (View on PubMed)

Labiris G, Panagiotopoulou EK, Perente A, Ntonti P, Delibasis K, Fotiadis I, Konstantinidis A, Dardabounis D. Premium Monovision versus Bilateral Myopic Monovision, Hybrid Monovision and Bilateral Trifocal Implantation: A Comparative Study. Clin Ophthalmol. 2022 Mar 4;16:619-629. doi: 10.2147/OPTH.S351091. eCollection 2022.

Reference Type DERIVED
PMID: 35282170 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ES13/Th9/22-10-2020

Identifier Type: -

Identifier Source: org_study_id